Nestle to acquire Aimmune for $2.6B

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Monday, Nestle announced it had offered $34.50 per share to acquire the remaining 74.4% of Aimmune Therapeutics, the peanut allergy treatment developer, valuing the company at $2.6B.
Back to articles

Actual Topics

Mon, 31 Aug 2020 07:50:35 GMT

US halts Philips ventilators order

Philips, the electrical equipment maker, said on Monday that the US Health Department had cancelled its order for 43K hospital ventilators, prompting the company to trim its 2020 earnings forecast.

Mon, 31 Aug 2020 05:13:27 GMT

Buffett buys 5% stakes in five large Japanese firms

Berkshire Hathaway has acquired 5% stakes in five biggest Japanese trading firms, the company's Chairman Warren Buffett announced on Sunday.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.